A deadly bargain

Brownlee, Shannon; Watson, Traci
April 1994
U.S. News & World Report;4/25/94, Vol. 116 Issue 16, p79
States that researchers announced they had discovered a crucial event that immortalizes cancer cells, allowing them to live indefinitely and multiply abundantly--until the surrounding cells, and the patient, perish. New cancer gene that wreaks its havoc in a wide variety of tumors; Discovery announced by Calvin Harley of a new paradigm in cancer therapy; Aging of cells; Enzyme called telomerase; Cellular destiny; More.


Related Articles

  • Thermodynamic Aspects of Cancer: Possible Role of Negative Entropy in Tumor Growth, its Relation to Kinetic and Genetic Resistance. Molnar, Joseph; Thornton, Barry S.; Molnar, Annamaria; Gaál, Dezso; Luo, Liaofu; Bergmann-Leitner, Elke S. // Letters in Drug Design & Discovery;Sep2005, Vol. 2 Issue 6, p429 

    Chemotherapy can result in partial or temporary remission, but often does not completely eradicate cancer. The treatment failures are, at least in part, due to tumor cell resistance to chemotherapeutics. One contributing factor for impaired responses to chemotherapy is that only proliferating...

  • The mystery of let-7d - a small RNA with great power. Kolenda, Tomasz; Przybyła, Weronika; Teresiak, Anna; Mackiewicz, Andrzej; Lamperska, Katarzyna M. // Contemporary Oncology / Wspolczesna Onkologia;2014, Vol. 18 Issue 5, p293 

    miRNAs belong to a class of small non-coding RNAs which can modulate gene expression. Disturbances in their expression and function may cause cancer formation, progression and cell response to various types of stress. The let-7 family is one of the most studied groups of miRNAs. The family...

  • PIK3CA mutation predicted pCR in HER-2-positive breast cancer. Altersitz, Katrina; Todak, Alexandra // Hem/Onc Today;1/25/2014, Vol. 15 Issue 2, p26 

    The article discusses studies which indicate the breast cancer mutation gene PIK3CA independently predicted pathologic complete response to neoadjuvant chemotherapy in patients with HER-2-positive, hormone-receptor-positive breast cancer.

  • Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion. Leilei Chen // Gut;Apr2011, Vol. 60 Issue 4, p534 

    BACKGROUND: Hepatocellular carcinoma (HCC) is among the most lethal of human malignancies. It is difficult to detect early, has a high recurrence rate and is refractory to chemotherapies. Amplification of 1q21 is one of the most frequent genetic alterations in HCC. CHD1L is a newly identified...

  • Whole-genome characterization of chemoresistant ovarian cancer. Patch, Ann-Marie; Christie, Elizabeth L.; Etemadmoghadam, Dariush; Garsed, Dale W.; George, Joshy; Fereday, Sian; Nones, Katia; Cowin, Prue; Alsop, Kathryn; Bailey, Peter J.; Kassahn, Karin S.; Newell, Felicity; Quinn, Michael C. J.; Kazakoff, Stephen; Quek, Kelly; Wilhelm-Benartzi, Charlotte; Curry, Ed; Leong, Huei San; Hamilton, Anne; Mileshkin, Linda // Nature;5/28/2015, Vol. 521 Issue 7553, p489 

    Patients with high-grade serous ovarian cancer (HGSC) have experienced little improvement in overall survival, and standard treatment has not advanced beyond platinum-based combination chemotherapy, during the past 30 years. To understand the drivers of clinical phenotypes better, here we use...

  • Development of treatment strategies for advanced neuroblastoma. Hara, Junichi // International Journal of Clinical Oncology;Jun2012, Vol. 17 Issue 3, p196 

    Neuroblastoma is the most common cancer in childhood. The majority of patients with neuroblastoma are assigned to the high-risk group based on age at diagnosis, stage, histology, MYCN status, and DNA ploidy. Their prognosis remains unsatisfactory; the 5-year event-free survival (EFS) rate is...

  • Cure Crusader. Thompson, Dick // Time;10/11/1999, Vol. 154 Issue 15, p72 

    Discusses the efforts of the late Cell Pathways pharmaceutical company founder, Floyd Nichols, to find a cure for familial adenomatous polyposis (FAP), a genetic disorder of cancerous polyps on the lining of the intestines. Studies on the aspirin-like arthritis drug called sulindac, which was...

  • Prospective study of paclitaxel and irinotecan for elderly patients with unresectable non-small cell lung cancer. Fumihiro Oshita; Shuji Murakami; Tetsuro Kondo; Haruhiro Saito; Kouzo Yamada // Journal of Experimental Therapeutics & Oncology;2013, Vol. 10 Issue 3, p203 

    We conducted a phase II study of combination chemotherapy with paclitaxel (Pac) and irinotecan (CPT) to determine the effects and toxicities in patients 70 years or older with unresectable non-small cell lung cancer (NSCLC). Eligible patients were entered to receive three courses of Pac at 160...

  • Understanding Histone Deacetylases in the Cancer Development and Treatment: An Epigenetic Perspective of Cancer Chemotherapy. Ahmad, Mudassier; Hamid, Abid; Hussain, Aashiq; Majeed, Rabiya; Qurishi, Yasrib; Bhat, Javeed Ahmad; Najar, Rauf Ahmad; Qazi, Asif Khurshid; Zargar, Mohmmad Afzal; Singh, Shashank Kumar; Saxena, Ajit Kumar // DNA & Cell Biology;Oct2012 Supplement, Vol. 31, pS-62 

    Cancer is a pathologic condition that involves genetic and epigenetic events culminating in neoplastic transformation. Alteration in epigenetic events that regulate the transcriptional activity of genes associated with various signaling pathways can influence multiple stages of tumorigenesis. In...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics